靶向活化转录因子6的短发夹RNA重组腺病毒载体构建及对猪瓣膜间质细胞增殖与凋亡的影响

详细信息    查看全文 | 推荐本文 |

英文篇名：Construction of shRNA recombinant adenovirus vector targeting ATF6 and its effect on proliferation and apoptosis of porcine valve interstitial cells 作者：田军 ; 刘晓红 ; 韩林 英文作者：TIAN Jun;LIU Xiaohong;HAN Lin;Department of Cardiothoracic Surgery, Changhai Hospital, Navy Military Medical University; 关键词：短发夹RNA ; 活化转录因子6 ; 重组腺病毒载体 ; 瓣膜间质细胞 ; 凋亡 英文关键词：Short hairpin RNA;;Activated transcription factor 6;;Recombinant adenovirus vector;;Valve interstitial cells;;Apoptosis 中文刊名：国际心血管病杂志 英文刊名：International Journal of Cardiovascular Disease 机构：海军军医大学附属上海长海医院胸心外科; 出版日期：2019-05-25 出版单位：国际心血管病杂志 年：2019 期：03 基金：国家自然科学基金(81770383,81570351) 语种：中文; 页：19-22 页数：4 CN：31-1951/R ISSN：1673-6583 分类号：R542.5

摘要

目的:构建猪活化转录因子6-短发夹RNA(ATF6-shRNA)重组腺病毒干扰载体,观察其对猪瓣膜间质细胞(VIC)增殖与凋亡的影响。方法:针对猪ATF6序列设计3个shRNA干扰靶点,构建质粒,包装后进行病毒扩增,使用腺病毒转染VIC,通过定量PCR检测腺病毒对VIC中ATF6的干扰效率,通过Western blot法测定下调ATF6后VIC中胱天蛋白酶(caspase)-3的表达情况,并通过CCK-8法检测VIC增殖情况。结果:成功构建靶向ATF6的shRNA重组腺病毒载体。腺病毒转染VIC后,腺病毒对VIC中ATF6干扰效率提高;而ATF6、 caspase-3表达显著降低;自第2天起VIC存活率升高,差异均有统计学意义(P均<0.05)。结论:成功构建靶向ATF6的shRNA重组腺病毒载体,通过降低VIC中ATF6的表达水平,减少VIC凋亡并促进细胞存活。
        Objective:To construct the short hairpin RNA(shRNA) recombinant adenoviral vector targeting the activating transcription factor 6(ATF6), and explore its effect on the proliferation and apoptosis of porcine valve interstitial cells(VIC). Methods:We identified 3 shRNA target sites based on the porcine ATF6 gene sequences. Then the plasmid was constructed and packaged for virus amplification. The interference efficiency was detected by quantitative PCR after porcine VIC were transfected by adenovirus vector carrying ATF6-shRNA, and the expression of caspase-3 in VIC was measured by western blot when down-regulating the ATF6. Furthermore, CCK-8 method was used to measure proliferation of VIC. Results:The recombinant adenovirus vector targeting ATF6, with high interference efficiency was constructed successfully. The expression of ATF6 and caspase-3 significantly decreased, and the survival rate of VIC increased since day 2 with statistical significance(all P<0.05). Conclusions:The recombinant adenovirus vector targeting ATF6 could be constructed successfully, which significantly reduces the expression of ATF6 in VIC, and decreases the apoptosis of VIC to promote their survival rate.

引文

[ 1 ] 黑飞龙,朱德明,侯晓彤,等.2016年中国心脏外科手术和体外循环数据白皮书[J].中国体外循环杂志,2017,15(2):65-67.
    [ 2 ] Cai Z,Li F,Gong W,et al.Endoplasmic reticulum stress participates in aortic valve calcification in hypercholesterolemic animals[J].Arterioscler Thromb Vasc Biol,2013,33(10):2345-2354.
    [ 3 ] Cai Z,Liu B,Wei J,et al.Deficiency of CCAAT/enhancer-binding protein homologous protein (CHOP) prevents diet-induced aortic valve calcification in vivo[J].Aging Cell,2017,16(6):1334-1341.
    [ 4 ] Rutkovskiy A,Malashicheva A,Sullivan GA,et al.Valve interstitial cells:the key to understanding the pathophysiology of heart valve calcification[J].J Am Heart Assoc,2017,6(9):e006339.
    [ 5 ] Huang J,Wan L,Lu H,et al.High expression of active ATF6 aggravates endoplasmic reticulum stress-induced vascular endothelial cell apoptosis through the mitochondrial apoptotic pathway[J].Mol Med Rep,2018,17(5):6483-6489.
    [ 6 ] Xiong YJ,Chen HT,Lin PF,et al.ATF6 knockdown decreases apoptosis,arrests the S phase of the cell cycle,and increases steroid hormone production in mouse granulosa cells[J].Am J Physiol Cell Physiol,2017,312(3):C341-C353.
    [ 7 ] 关丽英,许彩民,潘华珍.内质网应激介导的细胞凋亡[J].生物化学与生物物理进展,2007,34(11):1136-1141.
    [ 8 ] Liu MQ,Chen Z,Chen LX.Endoplasmic reticulum stress:a novel mechanism and therapeutic target for cardiovascular diseases[J].Acta Pharmacol Sin,2016,37(4):425-443.
    [ 9 ] Huang Y,Ye Y,Long P,et al.Silencing of CXCR4 and CXCR7 expression by RNA interference suppresses human endometrial carcinoma growth in vivo[J].Am J Transl Res,2017,9(4):1896-1904.
    [10] Peng YF,Shi YH,Ding ZB,et al.α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy[J].PLoS One,2013,8(2):e53072.